CPT code 88344 – Multiplex antibody stain procedure

Key takeaways

CPT code 88344 covers each multiplex antibody stain procedure, per specimen, in immunohistochemistry (IHC) and immunocytochemistry (ICC).

It applies when two or more antibodies sit on the same slide and each one is detected separately, usually with its own chromogen.

A cocktail of antibodies sharing one detection system is reported as 88342, and quantified markers such as ER, PR and HER2 take 88360 or 88361.

Documentation must name every antibody, state the multiplex detection method, give the clinical indication, and carry a pathologist’s interpretation.

Medicare pays 88344 under the MPFS, with Palmetto GBA LCD L35922 governing coverage in its Southeast jurisdiction, while BCBS NC requires notification or prior authorization.

CPT code 88344: Official descriptor and procedure overview

CPT code 88344 is “Immunohistochemistry or immunocytochemistry, per specimen; each multiplex antibody stain procedure,” as defined by the American Medical Association’s CPT code set. Each unit of service is one multiplex stain procedure on one pathology specimen.

Four conditions decide whether a stain qualifies:

• The stain is immunohistochemical or immunocytochemical, using antibodies rather than dyes or probes.
• Two or more antibodies are applied to the same slide within one staining procedure.
• Each antibody is separately identifiable, usually through its own chromogen or label.
• Billing is per specimen, so a second block from the same specimen adds no unit.

Common clinical contexts include lymphoma workups, such as a dual CD20/CD3 stain, and lung carcinoma typing with p40 and TTF-1 on one slide. Breast ER, PR, HER2 and Ki-67 profiling is usually quantitative IHC, reported with 88360 or 88361 instead. CPT revised the IHC code family in 2015, giving 88342 and 88341 their current single-antibody definitions.

What 88344 covers and what it excludes

CPT 88344 covers one multiplex stain: Two or more antibodies applied to the same slide of one specimen, with each antibody read separately. “Multiplex” is the operative word. Antibodies mixed into a cocktail with one shared detection system give the pathologist a single result. That stain is reported as 88342.

Several related procedures fall outside 88344, and each has its own code.

• Single-antibody stain, initial (88342): The first single-antibody stain on a specimen. An antibody cocktail read as one result is reported here too.
• Additional single-antibody stain, add-on (88341): Each additional single-antibody stain on the same specimen. 88341 is an add-on code and can’t be billed on its own.
• Special histochemical stains (88312-88314): Non-immunologic stains such as PAS, AFB, Masson’s trichrome and iron stains. These have their own code family and are not IHC.
• In situ hybridization (88364-88368): FISH and CISH use nucleic acid probes, not antibodies. Billing 88344 for ISH is a coding error.
• Quantitative IHC (88360, 88361): Per-antibody quantitation, done manually (88360) or computer-assisted (88361). It replaces 88342, 88341 or 88344 for that antibody rather than adding to them.

CPT 88344 vs 88342 vs 88341: How to choose the right code

The three most confused IHC codes share the same per-specimen billing logic but differ by antibody count and detection method. Choose based on exactly what was run on each specimen.

A common coding error is billing 88342 and 88341 units to describe a multiplex stain. When two or more antibodies on one slide are each read separately, report 88344, one unit per multiplex stain. A cocktail sharing one detection system can’t be read antibody by antibody, so it’s reported as 88342. Single-antibody stains on separate slides map to 88342 plus 88341 add-ons.

Run each stain through the four questions below before you pick a code.

How the procedure is performed and what triggers 88344

Understanding the laboratory workflow helps coders check that what was billed matches what was performed. A pathologist’s interpretation of the results is required for billing in all cases.

1. Specimen fixation and processing: The tissue specimen (biopsy, resection, or cytology cell block) is formalin-fixed and paraffin-embedded, then sectioned onto slides.
2. Antibody selection: The lab chooses two or more primary antibodies aimed at different antigens. Each one is paired with its own detection label, which is what makes the stain multiplex.
3. Antibody application on one slide: The antibodies are applied to the same slide within one staining procedure. This is the technical trigger for 88344 rather than 88342/88341 coding.
4. Separate detection: Different chromogens or fluorescent labels show each antibody’s binding pattern, so the pathologist reads every marker on one slide. Antibodies sharing one chromogen form a cocktail, reported as 88342.
5. Pathologist interpretation: The interpreting pathologist reviews the staining pattern for each antibody and documents the findings against the clinical question. This interpretation must be recorded in the pathology report to support billing.

Documentation requirements for billing CPT 88344

A claim for CPT code 88344 rises or falls on the pathology report. Payers, including CMS, expect the report to show that each antibody was applied to one slide and read separately. When building a clean claim for 88344, confirm each of these documentation elements is present before submission.

• Antibodies identified: List every antibody in the multiplex stain by name, with the clone where the lab records it (for example, p40 and TTF-1). Vague references to “a panel” are not enough.
• Detection method confirmed as multiplex: The report must state that the antibodies were applied to one slide and detected separately. Wording such as “dual immunohistochemical stain with distinct chromogens” makes this clear.
• Specimen source documented: Identify the tissue site, specimen type (biopsy, excision, cytology block), and any laterality where applicable.
• Clinical indication stated: Record why the multiplex IHC was ordered (for example, “evaluation for lymphoma” or “squamous versus adenocarcinoma typing”).
• Pathologist interpretation: The pathologist must document findings for each antibody in the stain and relate them to the clinical question. Unsigned or boilerplate interpretations are a denial trigger for commercial payers.
• Ordering provider identified: Note the name and NPI of the physician who ordered the IHC procedure.

Build these six elements into the LIS report template as required prompts. Each one is then captured when the pathologist signs out the case, not chased after a denial.

Medicare reimbursement rates and coverage for CPT 88344

Medicare pays for CPT code 88344 under the CMS Medicare Physician Fee Schedule (MPFS). Payment rates are updated annually. Check the current rate in the MPFS Look-Up Tool, using the non-facility rate for independent laboratory settings.

Coverage in the Southeast US Medicare jurisdiction is governed by Palmetto GBA Local Coverage Determination L35922. It covers special histochemical and immunohistochemical stains, including 88344. The LCD lists the ICD-10-CM diagnosis codes that establish medical necessity. It also limits the number of IHC stains billable per specimen in certain clinical contexts.

Payer requirements: Prior authorization and coverage policies

Prior authorization for CPT code 88344 is not universal, but several major payers require it. A missing prior auth leads to a non-covered denial that clinical grounds alone rarely overturn. Confirm requirements before the specimen is accessioned, not after the report is signed.

BCBS NC requires notification or prior authorization for IHC procedures under policy AHS P2018. Labs can check current requirements in the Blue Cross NC immunohistochemistry policy. Other regional BCBS plans keep similar policies under their own policy numbers. Approval from one BCBS affiliate doesn’t carry over to another.

Medicare generally does not require prior authorization for 88344. Medical necessity must still be established through ICD-10-CM diagnosis coding that maps to the applicable LCD. For commercial payers, build a payer-by-payer authorization matrix for your most frequently billed IHC codes, and update it whenever a payer issues a policy notice.

Common denial reasons for CPT 88344 and how to avoid them

CPT code 88344 denials tend to fall into five categories. Catching the pattern before submission costs less than working denials after the fact. A strong denial management workflow starts with prospective coding review, not reactive appeals.

• Wrong code selected (88342 submitted instead of 88344): A frequent error. A multiplex stain billed as one 88342 unit per antibody gets caught by NCCI edits or medical review. Code from the technical worksheet, not from the antibody count alone.
• Missing prior authorization: Commercial payers with a prior auth requirement deny on non-covered grounds when no authorization number is on file. This denial is almost never overturned on appeal without proof of retrospective authorization.
• Insufficient documentation of multiplex method: Medical reviewers reject claims when the report describes an IHC panel without confirming separate detection on one slide. Adding explicit multiplex wording to report templates removes this denial category.
• Bundling errors with 88341: Billing both 88344 and 88341 on the same specimen for the same staining event triggers NCCI bundling edits. 88341 is an add-on for additional single-antibody stains and doesn’t belong alongside 88344 for the same procedure.
• Medical necessity not established: These claims usually lack an ICD-10-CM diagnosis code that maps to the applicable LCD or payer policy. Link every 88344 claim to a specific, billable diagnosis the payer recognizes for multiplex IHC.

Labs that track denial codes in medical billing by CPT code can see which of these patterns drives the most write-offs. That tells them which upstream fix to make first.

ICD-10 codes commonly paired with CPT 88344

The ICD-10-CM diagnosis code linked to a CPT code 88344 claim establishes medical necessity. Payers use the diagnosis to confirm that multiplex IHC was clinically appropriate for the specimen. The diagnosis must reflect the clinical question behind the IHC order, not a presumed final diagnosis.

These examples reflect commonly paired codes. They are not payer-mandated combinations. Always select the ICD-10-CM code that reflects why the multiplex IHC was ordered, and for Medicare, confirm it is on the LCD’s covered diagnosis list. The AAPC Codify CPT lookup tool provides CPT-to-ICD-10 crosswalk data for checking that link.

How claims management software reduces 88344 denials

Many IHC denials start before the claim is built. A multiplex stain gets coded as two single stains, or a prior authorization never gets logged. The error only surfaces weeks later, when the remittance comes back.

Pabau, the practice management platform we build, keeps the claim and the visit in one record. Its claims management software sends 837P claims through our Claim.MD integration. You can check payer eligibility before submission and track each claim’s status after it goes out.

When the payer responds, the electronic remittance advice comes back into Pabau with its reason codes. A denied 88344 line shows up next to its claim. Your team can then correct the code or chase the authorization while the case is still fresh.

Stop losing revenue to preventable 88344 denials

Pabau helps pathology and specialty labs manage claims, track denials, and submit electronically through Claim.MD. See how integrated billing workflows reduce coding errors and accelerate reimbursement.

Book a demo

Conclusion

Code 88344 from the slide, not from the order. Two or more antibodies on one slide, each read separately, means 88344. A shared chromogen means 88342, and quantified markers belong under 88360 or 88361.

The trade-off is a minute more work at sign-out. Naming every antibody and the detection method in the report is what decides whether a medical review goes your way.

Pair that report discipline with a payer authorization matrix, and most avoidable 88344 denials never reach your remittance. Book a demo to see how Pabau tracks each IHC claim from submission to payment.

Continue your research

Need to understand how lab denials get resolved? Denial management in healthcare walks through the full denial workflow from root cause analysis to successful appeals.

Want to verify denial codes on rejected claims? Denial codes in medical billing is a reference guide to CARC and RARC codes used on 835 remittances.

Looking for guidance on clearinghouse claim submission? Medical claims clearinghouse explains how 837P transactions reach payers and where errors surface.

Coding a special stain instead of an antibody? CPT code 88313 covers group II special stains such as trichrome and iron, and how they differ from IHC.

Frequently asked questions